IL-6 neutralization and CD40 stimulation synergistically reduces GAMs-mediated immune suppression and enhances T-cell infiltration and activation in GBM, sensitizes GBM to immune checkpoint blockade. The gene discussed is IL6; the disease is glioblastoma.